fda glp-1 compounding crackdown news today FDA CRACKDOWN ESCALATES: 30 telehealth

Lillys new safety allegations add fuel to lawsuits and FDA actions targeting telehealth sellers of compounded weight loss drugs.

While we look forward to the emergence of new evidence that we hope will address these gaps, in the interim we provide a perspective, based on our collective clinical experience, on how best to manage glucose-lowering therapy as patients with Covid-19 recover from their disease and return to normal care.

No insurance billing means no barriers between you and the medications...

It is not approved for any of these yet, but the intent is clearly broader metabolic health, not just weight loss

Trial registration ClinicalTrials.gov NCT05071950

For decades, extensive research has aimed to clarify the role of pancreas and gut-derived peptide hormones in the regulation of glucose homeostasis and feeding behavior